510(k) · Radiology

TAIMedImg DeepMets

by Taiwan Medical Imaging Co., Ltd.

TAIMedImg DeepMets is an AI-enabled medical device from Taiwan Medical Imaging Co., Ltd. that the U.S. FDA cleared through 510(k) K250427 on May 28, 2025. Its lead review panel is Radiology and its primary product code is QKB (Radiological Image Processing Software For Radiation Therapy).

See also FDA-cleared AI radiology devices in 2025, all FDA AI clearances in 2025, top radiology AI devices.

Key facts

Submission numberK250427
Pathway510(k)
Date of final decision
Company (FDA list)Taiwan Medical Imaging Co., Ltd.
Lead review panelRadiology
Primary product codeQKB — Radiological Image Processing Software For Radiation Therapy
Applicant (openFDA)Taiwan Medical Imaging Co., Ltd.
Applicant locationKaohsiung City, TW
Device classClass 2
Regulation number21 CFR 892.2050
Decision codeSESE
Submission typeTraditional

Source: FDA AI-Enabled Medical Devices list and openFDA.

What this means

A 510(k) is a premarket submission showing the device is substantially equivalent to a legally marketed predicate device. A cleared 510(k) means FDA agreed with that equivalence. TAIMedImg DeepMets went through this pathway (K250427).

openFDA lists it as a Class 2 device under 21 CFR 892.2050. Class II devices are moderate risk and are subject to general and special controls.

Product code QKB covers 46 devices on the FDA AI list. By decision date, this device is #39 of 46 under that code. Taiwan Medical Imaging Co., Ltd. has 1 AI-enabled device on the list, and the Radiology panel accounts for 1,230 in total.

Being on this list doesn't describe how well the device works clinically. Check the FDA record for its indications for use.

Similar devices (product code QKB)